Who
Stephen Basso
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Innoviva; SVP Finance (PFO), Inozyme Pharma.
In numbers
- Trades disclosed
- 29
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 23 Jul 2020
- Last trade
- 20 Aug 2026
- Last filed
- 24 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Aug 2026filed 24 Aug 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code F | $12K558 at $21.00 | filing |
| 20 Aug 2026filed 24 Aug 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code F | $12K558 at $21.00 | filing |
| 20 May 2026filed 22 May 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code F | $12K559 at $22.24 | filing |
| 20 May 2026filed 22 May 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code F | $12K559 at $22.24 | filing |
| 15 May 2026filed 22 May 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —1,123 at $0.00 | filing |
| 15 May 2026filed 22 May 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —1,123 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —37,994 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —93,750 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —93,750 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —37,994 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code F | $29K1,244 at $23.39 | filing |
| 20 Feb 2026filed 24 Feb 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code F | $29K1,244 at $23.39 | filing |
| 20 Nov 2025filed 24 Nov 2025 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code F | $5,015237 at $21.16 | filing |
| 15 Nov 2025filed 24 Nov 2025 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —604 at $0.00 | filing |
| 3 Nov 2025filed 5 Nov 2025 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | $500K27,609 at $18.11 | filing |
| 20 Aug 2025filed 22 Aug 2025 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code F | $4,728237 at $19.95 | filing |
| 20 May 2025filed 22 May 2025 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code F | $4,451237 at $18.78 | filing |
| 15 May 2025filed 22 May 2025 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —1,353 at $0.00 | filing |
| 24 Feb 2025filed 26 Mar 2025 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —100,831 at $0.00 | filing |
| 24 Feb 2025filed 26 Mar 2025 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | $191K10,569 at $18.08 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.